PEPTIDEHARBOR
Home/Peptides Directory/Semax
Risk Level: LowIntranasalSubQ Inject

Semax

Potent BDNF Upregulator & Brain Fog Clearing Nootropic Heptapeptide
Aliases / Trademarks: ACTH(4-10) Analog ยท MEHFPGP

A synthetic heptapeptide derived from ACTH(4-10) stabilized with a C-terminal Pro-Gly-Pro sequence. Possesses zero hormonal activity while potently upregulating hippocampal BDNF and NGF expression to eliminate brain fog and boost cognitive endurance.

๐Ÿงฌ Stacking Blueprint (neuro-calm-stack)
Associated Protocol Category: View Protocol Roadmap
๐Ÿ“Š Reddit & Community Real-World Scorecard720 Aggregated Logs
95% Overall Satisfaction
Onset Speed Perception
4.9 / 5.0
Rapid onset within 24-48h
Injection Pain / PIP
1.0 / 5.0
SubQ injection virtually painless
Cost-to-Value Index
4.6 / 5.0
Highly cost-effective (~$30-$60/mo)

โฑ๏ธ Real-World Expectation & Sentiment Timeline

Click stages below to view milestone milestones & warnings
Day 1 - 3๏ผšBrain Fog Clearance & Effortless Focus Core Milestones
Noticeable surge in mental clarity within 15 minutes, feeling refreshed as if splashing cold water on the face
Cognitive friction when parsing dense technical documents or complex code decreases dramatically
Stage Critical Guidance:Use in the morning or early afternoon; avoid dosing after 3 PM to prevent sleep disruption.

Standard Dosage & Administration Guidelines

Typical Dose
200mcg - 600mcg / day
Frequency
1 - 2 times daily (morning or midday nasal spray / SubQ)
Cycle Length
2 - 4 weeks per cognitive sprint
Clinical & Community Notes: Intranasal spray is the commonly discussed route! Delivering peptides through the olfactory nerve endings bypasses the blood-brain barrier (BBB) within minutes, directly reaching the hippocampus with zero hepatic first-pass metabolism.

Titration Schedule & Dosing Decision Tree

Step-up Protocol
Starting & Maintenance Criteria:200mcg - 300mcg intranasally (1 drop/spray per nostril) in the morning
Maintain 200mcg - 400mcg daily for 2-4 weeks
Titration & Adjustment Rules:Can add an additional 200mcg dose at midday during intense cognitive demands
TimelineDosage & FrequencyObjectiveKey Biomarkers / Checks
Week 1200mcg - 300mcg daily (morning)Clear brain fog and establish baseline neurotrophic responsivenessMental clarity, daytime wakefulness
Weeks 2 - 3300mcg - 500mcg daily (split AM/midday)Peak cognitive sprint: working memory, verbal fluency, and complex problem-solvingSleep latency, evening relaxation
Week 4200mcg dailyConsolidation phase before scheduled off-cycleSustained focus on off days
Educational Composite Scenarios
1 Composite Archetypes
โ„น๏ธ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.

4-Week Semax Nootropic Protocol: Brain Fog Elimination & Laser Focus

๐Ÿ‘ค Composite Profile: Male, 27yo, medical postgrad preparing for licensing exams; suffered severe 3 PM brain fatigue and working memory lapses.

Illustrative Protocol: Semax 0.1% nasal spray (300mcg AM + 200mcg early afternoon), cycled 3 weeks on / 1 week off.
Illustrative Timeline:
Day 1Onset within 15 minutes
Within 15 min of nasal spray, mental clarity surged with zero peripheral jitters or elevated heart rate.
Week 2Sustained Focus 3h+
Afternoon mental crash vanished; ability to conceptualize complex biochemical pathways drastically improved.
Week 41-Week Washout with Zero Withdrawal
One week off cycle demonstrated zero rebound lethargy or withdrawal symptoms.
Scenario Outcome and Learning Points: Doubled high-intensity cognitive stamina, eliminated caffeine dependency, and passed board exams with top percentile scores.
๐Ÿ’ก Educational Takeaway: Semax acts directly via hippocampal BDNF upregulation. Angle nasal spray toward outer upper turbinate; cycle 3-on / 1-off to maintain receptor sensitivity.

Visual Syringe Reconstitution Calculator

Accurately calculate vial reconstitution concentration and U-100 syringe units

Syringe:
Quick Clinical & Community Presets:
mg
ml
mcg
Syringe Pull To Mark
7.5Units (Ticks on Syringe)
Equal to 0.075 ml fluid | Yields 40 doses
Conc: 3.33 mg/ml
๐Ÿ’‰ Visual Needle Simulation (U-100 Standard)Target: 7.5 / 100 U
01020304050607080901007.5 U
โ‘  Dissolution Technique: Slowly slide BAC water down the vial wall. Never shake vigorously to protect peptide chains.
โ‘ก Cold-Chain Storage: Store reconstituted liquid at 2-8ยฐC away from light. Best used within 28-30 days.
โ‘ข Standard Syringe: Calculation based on U-100 insulin syringes (100 units = 1.0 ml).

Evidence-Based FAQs & Reddit Theoretical Mythbusters

Verified biochemical mechanisms, category physiology, and Reddit misconception clarity

4 Verified Answers
1. Compound-Specific Dilemmas & Solutions
The olfactory epithelium in the upper nasal cavity connects directly to the olfactory bulb and CSF. Intranasal droplets absorb via olfactory and trigeminal nerve pathways directly into central nervous system tissue, bypassing systemic circulation and the BBB.
3. Theoretical Mechanisms & Reddit Mythbusters

๐Ÿ”— Synergistic Stacking Protocols (Synergies)

Synergy Stack

+ Selank

The definitive nootropic duo: Semax provides sharp executive focus while Selank eliminates stress-induced anxiety and mental chatter.

๐Ÿ“Š Educational Composite Scenarios (1)

Illustrative 6-16 week timelines, sample biomarker metrics, and educational protocol takeaways for Semax.

View All Scenarios Hub โ†’
โ„น๏ธ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.
Textbook ResponderMale, 27 y/oโ€ข4 Weeks Protocol

4-Week Semax Nootropic Protocol: Brain Fog Elimination & Laser Focus

Illustrative Protocol: Semax 0.1% nasal spray (300mcg AM + 200mcg early afternoon), cycled 3 weeks on / 1 week off.
Deep Work Duration
180
+300% (Effortless Flow State)
Daily Caffeine
0 - 50 mg
-87.5% (Zero Jitters)
Recall Accuracy
88.5%
+22% Exam Mock Scores
Illustrative Weekly Highlights:
Day 1Within 15 min of nasal spray, mental clarity surged with zero peripheral jitters or elevated heart rate.
Week 2Afternoon mental crash vanished; ability to conceptualize complex biochemical pathways drastically improved.
Week 4One week off cycle demonstrated zero rebound lethargy or withdrawal symptoms.
๐Ÿ’ก Educational Takeaway: Semax acts directly via hippocampal BDNF upregulation. Angle nasal spray toward outer upper turbinate; cycle 3-on / 1-off to maintain receptor sensitivity.
Inspect Full Scenario Dossier โ†’
Dedicated Dose & Syringe Calculator

๐Ÿ’‰ Semax Reconstitution & Syringe Tick Tool

Standard vial size: 10mg. Recommended BAC water: 3ml. Typical dose: 200mcg - 600mcg / day.

Visual Syringe Reconstitution Calculator

Accurately calculate vial reconstitution concentration and U-100 syringe units

Syringe:
Quick Clinical & Community Presets:
mg
ml
mcg
Syringe Pull To Mark
10Units (Ticks on Syringe)
Equal to 0.100 ml fluid | Yields 20 doses
Conc: 2.50 mg/ml
๐Ÿ’‰ Visual Needle Simulation (U-100 Standard)Target: 10 / 100 U
010203040506070809010010 U
โ‘  Dissolution Technique: Slowly slide BAC water down the vial wall. Never shake vigorously to protect peptide chains.
โ‘ก Cold-Chain Storage: Store reconstituted liquid at 2-8ยฐC away from light. Best used within 28-30 days.
โ‘ข Standard Syringe: Calculation based on U-100 insulin syringes (100 units = 1.0 ml).
Evidence Context and Common Questions
Semax Key Takeaways
Evidence Context and Common Questions
200mcg - 600mcg / day, administered 1 - 2 times daily (morning or midday nasal spray / SubQ) for a cycle length of 2 - 4 weeks per cognitive sprint. Consensus: Intranasal spray is the commonly discussed route! Delivering peptides through the olfactory nerve endings bypasses the blood-brain barrier (BBB) within minutes, directly reaching the hippocampus with zero hepatic first-pass metabolism.
Back to Peptides Directory

Research References

References may include preclinical or clinical research and do not establish safety, efficacy, or dosing for an individual.

Semax, an ACTH(4-10) analogue with nootropic properties, stimulates BDNF expression in the rat hippocampus
Neuroscience Letters ยท 2006
Open DOI: 10.1016/j.neulet.2006.07.014